Sector pending / Pharmaceutical PreparationsUpdated 2026-05-10 22:07 UTC

FRA/19KA stock hub

FRA/19KA has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

FRA/19KAis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

527.8M

Frankfurt Stock Exchange

Market data

Price

Recent price action with selectable time range.

FRA/19KAFRA/19KA

—

Loading chart…

In the news

Latest news · FRA/19KA

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E8.5

P25 n/aP50 n/aP75 n/a

Trailing P/E3.8

P25 n/aP50 n/aP75 n/a

ROE66.6

P25 n/aP50 n/aP75 n/a

ROIC36.7

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All FRA/19KA market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

183

Groups with data

Currency

USD

Showing 183 of 183 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	DE
Employees	191
Employees Change	126%
Employees Change Percent	193.8
Enterprise value	EUR 519.3M
Exchange	Frankfurt Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Pharmaceutical Preparations
Last refreshed	2026-05-10
Market cap	EUR 527.8M
Price	EUR 6.55
Price currency	EUR
Rev Per Employee	1,389,961.02x
Sic	2834
Symbol	fra/19KA
Website	https://cormedix.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	26.15%
EV Earnings	3.76x
EV/EBIT	3.81x
EV/EBITDA	3.49x
EV/FCF	3.53x
EV/Sales	1.96x
FCF yield	27.88%
Forward P/E	8.52x
P/B ratio	1.53x
P/E ratio	3.82x
P/S ratio	1.99x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	51.44%
EBITDA Margin	56.11%
FCF margin	55.43%
Gross margin	92.91%
Gross Profit	EUR 246.7M
Gross Profit Growth	616.21%
Gross Profit Growth Q	290.36%
Gross Profit Growth3 Y	1,574.59%
Gross Profit Growth5 Y	509.67%
Net Income	EUR 138M
Net Income Growth Q	4.13%
Pretax Margin	48.13%
Profit Margin	52.31%
Profit Per Employee	EUR 722,683
ROA	21.21
Roa5y	-19.1
ROCE	24.6
ROE	66.56
Roe5y	-26.75
ROIC	36.73

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-32.14%
Cagr3y	14.01%
EPS Growth Q	-28.28
Revenue Growth	617.03x
Revenue Growth Q	312.1x
Revenue Growth3 Y	1,582.83x
Revenue Growth5 Y	319.75x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.66
Assets	EUR 703.6M
Cash	EUR 126.5M
Current Assets	EUR 311.2M
Current Liabilities	EUR 147.8M
Debt	EUR 126.8M
Debt EBITDA	EUR 0.85
Debt Equity	EUR 0.37
Debt FCF	EUR 0.86
Equity	EUR 345.2M
Interest Coverage	57.64
Liabilities	EUR 358.4M
Long Term Assets	EUR 392.4M
Long Term Liabilities	EUR 210.7M
Net Cash	EUR 8.5M
Net Cash By Market Cap	EUR 1.61
Net Cash Growth	-80.49%
Net Debt EBITDA	EUR -0.06
Net Debt Equity	EUR -0.02
Net Debt FCF	EUR -0.06
Tangible Book Value	EUR -3.2M
Tangible Book Value Per Share	EUR -0.04

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.11
Inventory Turnover	1.18
Net Working Capital	EUR 38.9M
Quick ratio	1.83
Working Capital	EUR 164.2M
Working Capital Turnover	EUR 1.94

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-36.41%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-32.12%
200-day SMA	8.23
3Y total return	48.19%
50-day SMA	5.87
50-day SMA vs 200-day SMA	50under200
All Time High	15
All Time High Change	-56.33%
All Time High Date	2021-02-22
All Time Low	0.64
All Time Low Change	923.44%
All Time Low Date	2018-03-29
ATR	0.18
Ch YTD	-38.21
High	6.55
High52	14.6
High52 Date	2025-06-24
High52ch	-55.14%
Low	6.55
Low52	5.2
Low52 Date	2026-03-23
Low52ch	25.96%
Ma50ch	11.53%
Price vs 200-day SMA	-20.44%
RSI	58.1
RSI Monthly	47.64
RSI Weekly	46.13
Sharpe ratio	-0.29x
Sortino ratio	-0.34
Total Return	-36.41%
Tr YTD	-38.21
Tr1m	10.61%
Tr1w	1.61%
Tr3m	9.17%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR 136.6M
Operating Income Growth Q	435.9
Operating margin	51.44

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	67,521,600%
Net Borrowing	127,034,883.1
Shares Insiders	7.17%
Shares Institutions	46.67%
Shares Qo Q	8.94%
Shares Yo Y	36.41%
Short Ratio	11.98

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR 135.4M
Average Volume	10x
Bv Per Share	4.36
CAPEX	EUR -1.9M
Ch1m	10.61
Ch1w	1.61
Ch1y	-32.12
Ch3m	9.17
Ch3y	48.19
Ch6m	-28.42
Change	-1.24%
Change From Open	0
Close	6.63
Days Gap	-1.21
Depreciation Amortization	12,336,999.1
Earnings Date	2026-05-14
EBIT	EUR 136.6M
EBITDA	EUR 149M
EPS	EUR 1.74
F Score	5
FCF	EUR 147.2M
FCF EV Yield	28.34x
Financing CF	203,090,420
Fiscal Year End	December
Founded	2,006
Goodwill	25,440,555.9
Graham Number	12.84898
Graham Upside	96.17
Income Tax	EUR -11.1M
Investing CF	-262,689,831
Is Primary Listing	0
Last Earnings Date	2026-03-05
Last Report Date	2025-12-31
Last Split Date	2019-03-26
Last Split Type	Reverse
Ma150	7.48
Ma150ch	-12.41%
Ma20	6.25
Ma20ch	4.77%
Net CF	89,487,267
Next Earnings Date	2026-05-14
Open	6.55
P FCF Ratio	3.59
P OCF Ratio	3.54
Ppne	8,416,022.9
Price Date	2026-05-08
Price EBITDA	EUR 3.54
Relative Volume	20x
Revenue	265,482,555x
SBC By Revenue	4.44x
Share Based Comp	11,780,714
Tax By Revenue	-4.18x
Tr6m	-28.42%
Volume	0
Z Score	2.13

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does FRA/19KA pay a dividend?

Capital-return profile for this ticker.

Performance

FRA/19KA stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns FRA/19KA?

Insider, institutional, and short-interest positioning.

Institutional ownership

+46.7%

Share of float held by funds and institutions

Insider ownership

+7.2%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

FRA/19KA momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

58.1

Neutral momentum band

Price vs 200-day MA

-20.4%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

-0.29

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About FRA/19KA

Hub-level FAQ points readers to the deeper analysis pages.

What is the current fra/19KA stock rating?

fra/19KA is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full fra/19KA analysis?

The full report lives at /stocks/fra/19KA/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for fra/19KA?

The latest report frames fra/19KA around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the fra/19KA page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.